Szwarc I - Search Results

1

IgG3 donor-specific antibodies with a proinflammatory glycosylation profile may be associated with the risk of antibody-mediated rejection after kidney transplantation.

Pernin V, Bec N, Beyze A, Bourgeois A, Szwarc I, Champion C, Chauvin A, Rene C, Mourad G, Merville P, Visentin J, Perrochia H, Couzi L, Larroque C, Le Quintrec M. Pernin V, et al. Among authors: szwarc i. Am J Transplant. 2022 Mar;22(3):865-875. doi: 10.1111/ajt.16904. Epub 2021 Dec 18. Am J Transplant. 2022. PMID: 34863025 Free article.

2

[Delayed graft function: a frequent but still unsolved problem in renal transplantation].

Szwarc I, Garrigue V, Delmas S, Deleuze S, Chong G, Mourad G. Szwarc I, et al. Nephrol Ther. 2005 Dec;1(6):325-34. doi: 10.1016/j.nephro.2005.08.003. Epub 2005 Nov 16. Nephrol Ther. 2005. PMID: 16895703 Review. French.

3

Cinacalcet chloride is efficient and safe in renal transplant recipients with posttransplant hyperparathyroidism.

Szwarc I, Argilés A, Garrigue V, Delmas S, Chong G, Deleuze S, Mourad G. Szwarc I, et al. Transplantation. 2006 Sep 15;82(5):675-80. doi: 10.1097/01.tp.0000232452.80018.ad. Transplantation. 2006. PMID: 16969292

4

Ischemic postconditioning prevents ischemic acute renal failure.

Szwarc I, Soullier S, Gayrard N, Mejean C, Mourad G, Argiles A. Szwarc I, et al. Transplant Proc. 2007 Oct;39(8):2554-6. doi: 10.1016/j.transproceed.2007.08.026. Transplant Proc. 2007. PMID: 17954171

5

Does reduction in immunosuppression in viremic patients prevent BK virus nephropathy in de novo renal transplant recipients? A prospective study.

Alméras C, Foulongne V, Garrigue V, Szwarc I, Vetromile F, Segondy M, Mourad G. Alméras C, et al. Among authors: szwarc i. Transplantation. 2008 Apr 27;85(8):1099-104. doi: 10.1097/TP.0b013e31816a33d4. Transplantation. 2008. PMID: 18431228

6

Outcome of renal transplant recipients admitted to an intensive care unit: a 10-year cohort study.

Klouche K, Amigues L, Massanet P, Garrigue V, Delmas S, Szwarc I, Beraud JJ, Mourad G. Klouche K, et al. Among authors: szwarc i. Transplantation. 2009 Mar 27;87(6):889-95. doi: 10.1097/TP.0b013e31819a688a. Transplantation. 2009. PMID: 19300193

7

Post-conditioning to reduce renal ischaemia/reperfusion injury.

Szwarc I, Mourad G, Argiles A. Szwarc I, et al. Nephrol Dial Transplant. 2009 Jul;24(7):2288-9; author reply 2289-90. doi: 10.1093/ndt/gfn663. Epub 2009 Apr 1. Nephrol Dial Transplant. 2009. PMID: 19339341 No abstract available.

8

Evolution of coronary artery calcifications following kidney transplantation: relationship with osteoprotegerin levels.

Bargnoux AS, Dupuy AM, Garrigue V, Jaussent I, Gahide G, Badiou S, Szwarc I, Deleuze S, Vernhet H, Cristol JP, Mourad G. Bargnoux AS, et al. Among authors: szwarc i. Am J Transplant. 2009 Nov;9(11):2571-9. doi: 10.1111/j.1600-6143.2009.02814.x. Epub 2009 Sep 22. Am J Transplant. 2009. PMID: 19775319 Free article.

9

Early high pulse pressure is associated with graft dysfunction and predicts poor kidney allograft survival.

Vetromile F, Szwarc I, Garrigue V, Delmas S, Fesler P, Mimran A, Ribstein J, Mourad G. Vetromile F, et al. Among authors: szwarc i. Transplantation. 2009 Nov 15;88(9):1088-94. doi: 10.1097/TP.0b013e3181ba1585. Transplantation. 2009. PMID: 19898204

10

Monthly screening for BK viremia is an effective strategy to prevent BK virus nephropathy in renal transplant recipients.

Alméras C, Vetromile F, Garrigue V, Szwarc I, Foulongne V, Mourad G. Alméras C, et al. Among authors: szwarc i. Transpl Infect Dis. 2011 Apr;13(2):101-8. doi: 10.1111/j.1399-3062.2011.00619.x. Epub 2011 Mar 3. Transpl Infect Dis. 2011. PMID: 21371220

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

47 results

Search Page